Projects

National

• DNA methylation changes accompanying the development of multidrug resistance
  Program: VEGA
  Duration: 1. 1. 2024 – 31. 12. 2027

• Use of recombinant enzymes with thioglucosidase activity for the transformation of plant glucosinolates and their analogues into biologically active substances with preventive and suppressive effect on neoplasia development
  Program: SRDA
  Duration: 1. 7. 2023 – 30. 6. 2027

• Monitoring the interconnection of molecular events leading to the development of multidrug resistance in leukemic cells
  Program: VEGA
  Duration: 1. 1. 2021 – 31. 12. 2024

• Defense mechanisms of microbial and animal cells in reducing their sensitivity to plant defensive compounds
  Program: SRDA
  Duration: 1. 7. 2020 – 30. 6. 2024

• Multidrug resistance of leukemia cells - Phenotype caused by interference of multimodal molecular reasons
  Program: SRDA
  Duration: 1. 7. 2020 – 30. 6. 2024

• De novo pyrimidines synthesis inhibition as a potential treatment for acute myeloid leukemia with resistance to hypomethylating agents
  Program:
  Duration: 1. 1. 2022 – 31. 12. 2022